Osteoporosis: Positioning synthetic teriparatide in South African clinical practice
The use of teriparatide as an anabolic agent is essential to reducing fractures in very high risk patients, such as postmenopausal women and men with severe osteoporosis
Learning objectives
You will learn to:
• Interpret the National Osteoporosis Foundation of South Africa (NOFSA guidelines) on the use
of anabolic agents in osteoporosis
• Understand the clinical impact of the introduction of synthetic generic teriparatide as a ‘build
and maintain’ strategy for patients at very high risk of developing osteoporosis
• Ensure the individualised use of teriparatide for postmenopausal women, men with severe
osteoporosis and those who are at very high fracture risk.
To access this module, please register or login: